Reverse translation
Starting drug development from existing human clinical data and working backward to identify mechanisms and compositions, rather than moving from animal models forward
As defined in Finch Therapeutics: Empowering Immune Systems
Where it comes up · 1
Most important claims · 3 of 3Search all claims for “Reverse translation” →
- Placebo-controlled trials cannot be eliminated and their enrollment time is a near-fixed cost, so the largest efficiency gains come before trials by mining existing clinical data to identify responsive populations and design better trials.Finch Therapeutics: Empowering Immune Systems
- Finch holds a biorepository of more than 10,000 samples from patients, linked to outcomes, so specific strains that induced remission can be identified, cryo-revived, and grown as drug components.Finch Therapeutics: Empowering Immune Systems
- Finch only invests in a new program when clinical data already shows the composition works, a reverse-translation approach that starts from human outcomes rather than animal models and reduces early drug development risk.Finch Therapeutics: Empowering Immune Systems